Brian C Stephenson, Chief Financial Officer at Faeth Therapeutics, bought SNSE on Jun 24, 2026
Prices as of Jun 11 · price update delayed · Every feed →
▲ BUY$91.7K3,400 shares at $26.98Brian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.
- Traded
- Jun 24, 2026
- Disclosed
- Jun 26, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
SNSE since disclosure
SNSE has not closed a trading day since the disclosure yet
Similar stocks (XLV) since disclosure
SNSE has not closed a trading day since the disclosure yet
XLV — its sector index fund
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$34.7Kdisclosed Jun 26 · filed the same day
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$2.6Kdisclosed Jun 26 · filed the same day
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$13.7Kdisclosed Jun 26 · filed the same day
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$105Kdisclosed Jun 26 · filed the same day
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$77.9Kdisclosed Jun 26 · filed 2 days after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$2.8Kdisclosed Jun 26 · filed 2 days after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$72.9Kdisclosed Jun 26 · filed 2 days after the trade